GE HealthCare Cuts Profit Outlook Amid War-Related Woes and Inflation
GE HealthCare posted Q1 2026 revenue of $5.1 billion, exceeding estimates, but trimmed its full-year profit outlook due to surging chip and oil prices. The company cited supplier issues and higher costs as factors in its reduced guidance. Its stock fell despite the company's better-than-expected results.
GE HealthCare Technologies Inc. reported first-quarter 2026 earnings on April 29, posting revenue of $5.13 billion according to. Although the revenue beat FactSet estimates of $5.03 billion, the company's adjusted earnings per share (EPS) of $0.99 fell short of the expected $1.05.
Despite the better-than-expected revenue, GE HealthCare's shares dropped due to its reduced full-year profit outlook and concerns about the ongoing conflict and inflationary pressures. The company cited higher chip and oil prices as factors in its reduced guidance, which fell to a range of $4.80 to $5.00, below FactSet estimates of $5.06.
The company's quarterly earnings report also highlighted issues with suppliers and increased costs, which impacted profits. Despite these challenges, GE HealthCare remains a significant player in the healthcare sector.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis